Prisma Health CSO Dr. Alain Litwin joins SCbio Strategic Advisory Board
August 22, 2024
SCbio welcomed Prisma Health Chief Scientific Officer Dr. Alain Litwin, MD, MPH, MS, to its Strategic Advisory Board.
As Chief Scientific Officer, Litwin provides strategic and operational direction, promotes the success of investigators and academic partners, turns discovery into commercialization and disperses advances nationally and globally. Alongside his leadership at Prisma Health, Litwin also serves as a professor of psychology at Clemson University and of medicine at the University of South Carolina School of Medicine Greenville, where he was recognized as Scholar of the Year. As a fellow of the Aspen Health Innovators Fellowship’s fifth class and a member of the Aspen Global Leadership Network, Litwin is known for his record of developing, fostering and maintaining partnerships among diverse stakeholders, including academia, state and federal governments and industry.
Dr. Alain Litwin
Litwin is the Principal Investigator of the HERO national trial, funded by The Patient-Centered Outcomes Research Institute, which spans 23 sites in eight states. His work is known nationally and internationally, leading to over $60 million in grants and more than 150 publications in well-known journals such as JAMA and Annals of Internal Medicine. He also leads a multi-institutional National Institute of Health accelerator program and was recognized by Gov. Henry McMaster for his tireless work in championing the science of addiction.
After joining Prisma Health in 2017, Litwin served as Executive Director of the Prisma Health Addiction Medicine Center and Vice Chair of Academics and Research in the Department of Medicine Prisma Health Upstate. He earned his undergraduate degree in neurobiology at the University of California, Berkley, his medical degree and master’s in public health from Tulane University School of Medicine and a master’s in science in clinical research methods from Albert Einstein College of Medicine.
About SCbio
SCbio is South Carolina’s member-driven economic development organization exclusively focused on building, advancing and growing the life sciences industry in the state. SCbio represents more than 1,000 organizations employing more than 87,000 professionals across the state and supports and advances organizations in multiple arenas including pharmaceuticals, medical devices and equipment, digital health, research and medical labs, bioscience distribution, bio-ag and more. For additional information about SCbio and the life sciences industry, visit www.SCbio.org.
